Home > PJ (current issue) > Letters | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7220 p565-568
19 October 2002

This page
Reprint
Photocopy

   

PDF 155K

Letters

  Supervision
  CPD
  Sociology
  Parkinson's disease
  Modernisation
  Workforce census
  Eye drops
  Diverticular disease


Letters to the Editor

  * PDF files on PJ Online require Acrobat Reader 4 or later.

Modernisation

Opportunity to ensure a better balance missed

From Dr W. Dawson, FRPharmS

I read with interest the debate in Council and the subsequent decisions on the composition of a future — or was it reformed — Council (PJ, 12 October, pp545–8). I am bitterly disappointed that the opportunity was missed to ensure a better balance of representation among the pharmacist members of the future Council. I understand from the President’s presentation at the British Pharmaceutical Conference in Manchester (PJ, 28 September, p445–6) that professional advisory boards would be used to provide suitable advice to Council where this is seen as useful by either Council or the board. To me this misses the point that, in debate within the Council chamber broad professional experience should be brought to bear on all matters for debate and decision. We cannot allow the only breadth in discussion to be provided by the lay members of the Council and, with great respect, the evidence to date does not suggest that our democratic process provides such breadth within our current Council members.

It also seems illogical, having had no distinctions on residence, region or professional specialism for Council membership since the Society began, we can now allow regional nomination for both lay and pharmacist members but no sectoral qualifications. It may be politically correct but it does not seem to ensure functional effectiveness. Assuming the logic of Scottish and Welsh reserved places, then sectoral representation should be equally valid and I see no issues in creating a structure where representation is by election but within a defined structure of Council places. If four pharmacist places were reserved in such a way — perhaps Scotland, Wales, and two from education, industry or science — I think Council would be the better for it.

My only hope in the debate is the comment from Dr Evans (PJ, 12 Oct, p548) who notes that the constant drip of decision making is, in a sense, interim and that the submission of the total process will require the package to show integration and functionality. Perhaps a more effective consultation process might inform Council members as they move towards the final vote and I encourage the President and Council to try to achieve this. It is clear that neither questionnaires in The Journal nor requests to write to the modernisation steering group stimulate a wide response but the meeting at BPC showed that there was tremendous interest in active dialogue between membership and Council.


W. Dawson
Alton, Hampshire

 

Changing the Charter

From Mr D. Simpson, FRPharmS

Just for the record, Ashwin Tanna did not quite get his fractions right when he raised the question in the Council meeting about the majorities required to change the Charter and thereby the number of elected members on the Society’s Council (PJ, 12 October, p548).

A motion in the Council would require a majority of three-quarters (not two-thirds) of members present and voting. This, as Mr Tanna correctly suggests, must be confirmed by a special general meeting of members convened for the purpose by a majority of the same order. This was fully explained by John Ferguson, the Society’s former secretary and registrar, in his letter published on 5 October (p484).

The current Secretary and Registrar, Ann Lewis, suggested in response to Mr Tanna that the now intended changes might be effected by an Order under Section 60 of the Health Act 1999. But the wording of Section 60 makes it clear that such an Order can only be made for the purpose of regulation of the profession. Thus an Order can only be used in connection with the Society’s regulatory duties, and not its representational and association functions.

It is my opinion that the changes in the composition of the Council that are now envisaged go beyond regulation and would require a change in the Charter, which would require a motion of the Council with a three-quarters majority followed by a special general meeting. I do not see how these steps can be avoided. The Council will, thus, have no option but to provide a forum at which the members can make their views known and vote on the proposals that have now been made to alter the size of the Council and greatly increase the number of lay members (PJ, 28 September, p463).

Douglas Simpson
Beckenham, Kent

 

Will fees be halved?

From Ms A. Farrelly, MRPharmS

No taxation without representation! If the numbers of pharmacists represented on the Council are halved will our fees also be halved?

Ann Farrelly
Wallington, Surrey

 

Send your letter to The Editor

Previous Topic (Parkinson's disease)
Next Topic (Workforce census)

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal